Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D
- Conditions
- Ventricular Tachycardia (VT)Ventricular Fibrillation
- Registration Number
- NCT06745778
- Lead Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Brief Summary
The goal of this observational study is to investigate the changes of LBB EGM during daily activities and overdrive pacing at the time of peri-implantation and up to 6-month follow-ups of ICD/CRT-D patients. The main question it aims to answer is:
• Does the LBBP lead can provide accurate, stable, and valid EGM for ICD/CRT-D sensing and detection of ventricular tachyarrhythmia events? In each patient intracardiac EGMs of LBBP lead will be collected by ambulatory Holter monitor at the time of peri-implantation and up to 6-month follow-up. EGM collection will be collected at resting and walking conditions and overdrive pacing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Patients aged >=18 yrs.
- Patients indicated for ICD or CRT-D (primary or secondary prevention)
- Patients who recently (<=30 days) received ICD/CRT-D implantation with LBBP
- Patients' EGM can be digitally recorded
- Patients are willing to participate in the study and provide signed informed consent
- Patients received CIED upgrade or replacement with old pacing leads
- Patients are pregnant
- Patients participate in another study that will confound this study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method R-wave amplitude of LBB EGM At the enrollment, 3 months after enrollment and 6 months after enrollment Amplitude in millivolt
- Secondary Outcome Measures
Name Time Method EGM morphology-LVAT At the enrollment, 3 months after enrollment and 6 months after enrollment LVAT in millisecond, calculated based on electrogram recorded by LBB lead
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
The First Affiliated Hospital of Wenzhou Medical University
🇨🇳Wenzhou, Zhejiang, China
Shanghai Tongren Hospital
🇨🇳Shanghai, China